FDA.reportPublic FDA data

maraviroc 20 MG/ML Oral Solution [Selzentry]

RxCUI
1857925
RxNorm name
maraviroc 20 MG/ML Oral Solution [Selzentry]
Display name
maraviroc 20 MG/ML Oral Solution [Selzentry]
Full name
maraviroc 20 MG/ML Oral Solution [Selzentry]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:56

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SELZENTRYMARAVIROCViiV Healthcare Company46f30ac5-c96b-429e-976d-8c5ee1c0761b2022-09-26Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1857925

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
46f30ac5-c96b-429e-976d-8c5ee1c0761bmaraviroc 20 MG/ML Oral Solution [Selzentry]SBD25These highlights do not include all the information needed to use SELZENTRY safely and effectively. See full prescribing information for SELZENTRY. SELZENTRY (maraviroc) tablets, for oral use SELZENTRY (maraviroc) oral solution Initial U.S. Approval: 200720220926
46f30ac5-c96b-429e-976d-8c5ee1c0761bSelzentry 20 MG in 1 mL Oral SolutionPSN25These highlights do not include all the information needed to use SELZENTRY safely and effectively. See full prescribing information for SELZENTRY. SELZENTRY (maraviroc) tablets, for oral use SELZENTRY (maraviroc) oral solution Initial U.S. Approval: 200720220926
46f30ac5-c96b-429e-976d-8c5ee1c0761bSelzentry 20 MG per 1 ML Oral SolutionSY25These highlights do not include all the information needed to use SELZENTRY safely and effectively. See full prescribing information for SELZENTRY. SELZENTRY (maraviroc) tablets, for oral use SELZENTRY (maraviroc) oral solution Initial U.S. Approval: 200720220926